{"filings":[{"id":611796,"accession_number":"0001213900-26-060662","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-05-22T21:15:15+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical receives Nasdaq delisting notice for failing minimum stockholders' equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reported stockholders' equity of $1.895M as of March 31, 2026, below Nasdaq's $2.5M minimum.","Must submit a plan to regain compliance by July 6, 2026; Nasdaq may grant up to 180-day extension.","Currently does not meet alternative compliance standards based on market value or net income.","Notice has no immediate effect on trading; company intends to submit compliance plan but no assurance of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":40692,"accession_number":"0001213900-26-055085","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-05-12T20:16:15+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenon Medical Q1 2026 revenue $1.4M (+90% YoY), gross margin expands to 68.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1.4M, up ~90% YoY from $0.7M; gross profit $0.9M, up ~193% YoY.","Gross margin improved 24 percentage points to 68.5% from 44.5% in Q1 2025.","Net loss $3.5M ($0.31/share) vs $3.6M ($1.01/share); cash $4.6M at quarter end.","Closed $4.3M senior convertible note private placement to fund commercial expansion and development.","Post-quarter: opened Center of Excellence in Tampa, FL and expanded Eastern region sales leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105430,"accession_number":"0001213900-26-031840","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-03-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tenon Medical Q4 revenue $1.5M (+92% YoY); full year $3.9M (+20%); FDA clearance for next-gen SI fusion system","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1.5M (+92% YoY); gross margin improved to 69% from 46%.","Full year 2025 revenue $3.9M (+20% YoY); gross margin 60%, up from 52%.","Net loss improved: Q4 loss $2.8M ($0.29/sh) vs $3.1M ($0.98/sh); full year loss $12.6M ($1.70/sh) vs $13.7M ($11.26/sh).","Received FDA 510(k) clearance for SImmetry+ SI Joint Fusion System, expanding to lateral approach.","Closed $4.3M convertible note offering in March 2026; cash $3.8M at year-end, no debt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105429,"accession_number":"0001213900-26-028569","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical closes $4.3M private placement of senior convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate gross proceeds of $4.3M from senior convertible promissory notes with 20% original issue discount.","Notes mature September 11, 2026 (extendable to December 11, 2026); conversion at 80% of 3-day VWAP after six months.","Net proceeds for commercial expansion, product development, clinical studies, and working capital.","WallachBeth Capital acted as placement agent; notes unregistered under Regulation D.","If maturity extended, principal increases 5%; prepayment at 102.5% plus 15% of net proceeds from future financings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105428,"accession_number":"0001213900-26-021682","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical receives Nasdaq notice of non-compliance with $1.00 minimum bid price; 180-day cure period until Aug 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq letter dated Feb 25, 2026: common stock failed to maintain $1.00 bid price for 30 consecutive business days.","Company has until Aug 24, 2026 to regain compliance by closing at $1.00+ for 10 consecutive business days.","If not cured, may qualify for additional 180-day period by meeting other listing standards and intending to reverse split.","No immediate impact on listing; stock continues to trade under symbol TNON.","Management is evaluating options, including reverse stock split, to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105427,"accession_number":"0001213900-26-013278","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical pre-announces Q4 2025 revenue ~$1.5M (+90% YoY); FY 2025 rev ~$3.9M (+20%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary Q4 2025 revenue of $1.45M-$1.48M (unaudited), ~90% increase year-over-year.","Preliminary FY 2025 revenue of $3.91M-$3.94M, representing ~20% YoY growth.","Full Q4 and FY 2025 results to be released after market close on March 19, 2026, with conference call at 4:30 p.m. ET.","No additional financial details (net income, EPS) provided in this preliminary announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":3944000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121709,"accession_number":"0001213900-25-111522","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical closes $2.85M PIPE offering of 2.2M shares and warrants at $1.285/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 2,217,904 shares and warrants to purchase same number at combined $1.285/unit; warrants exercisable at $1.16 for 3 years.","Gross proceeds of ~$2.85M; net to be used for working capital, product launches, commercial expansion, clinical studies.","Offering included participation from CEO Steven Foster, CCO Nathaniel Grawey, CIO Wyatt Geist, and other accredited investors.","The PIPE closed on November 14, 2025; securities sold under Regulation D exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121707,"accession_number":"0001213900-25-100037","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K/A","filed_at":"2025-10-17T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Tenon files SiVantage financials; 2024 rev $1.04M, net loss $1.52M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["SiVantage 2024 revenue $1,039k, net loss $1,518k; six months ended June 30, 2025 rev $773k, net loss $995k.","As of June 30, 2025, SiVantage total assets $1,202k and stockholders' deficit $299k.","Asset acquisition closed Aug 1, 2025; financials for FY2024 and H1 2025 now filed with this 8-K/A.","Accumulated deficit grew from $2,875k (Dec 2024) to $3,870k (Jun 2025)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121708,"accession_number":"0001213900-25-099596","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tenon Medical grants 866,642 RSUs to directors and officers, vesting in 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 866,642 restricted stock units to directors and officers under 2022 Equity Incentive Plan.","RSUs vest 50% on January 1, 2026, and 50% on July 31, 2026.","Each RSU converts one-for-one into shares of common stock upon vesting.","Issued in reliance on Section 4(a)(2) exemption from registration as a non-public offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138388,"accession_number":"0001213900-25-090627","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenon Medical shareholders approve warrant exercisability and equity plan increase at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected: Ferrari, Foster, Ginn, Hochschuler, Howard, Jacques, Weigle each received >2.48M votes for.","Approved exercisability of Series C-1 (up to 2,445,700 shares) and C-2 (up to 1,222,850 shares) warrants at $1.25/share; 2,517,314 for, 120,940 against.","2022 Equity Incentive Plan amendments approved: share reserve increased from 189,870 to 1,328,365 shares; evergreen provision modified to up to 4% outstanding annually.","Ratified Haskell & White LLP as independent auditor for FY2025 with 4,488,067 votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138387,"accession_number":"0001213900-25-072781","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","2.01","3.02","7.01","9.01"],"status":"ready","headline":"Tenon Medical acquires SiVantage and SIMPL Medical assets, hires former SiVantage founders as executives","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired substantially all assets of SiVantage (SImmetry) and SIMPL Medical on Aug 1, 2025, for cash, stock, and royalties.","SImmetry consideration includes $750K cash, 710,300 shares (473,533 pledged for 1 year), royalty 15%/10% over 5 years (cap $5M), up to $1.3M deferred cash, and earnout shares.","SIMPL consideration: 30% royalty on net revenue for 5 years (20% after aggregate exceeds $20M); optional stock payment up to 33.3% of quarterly royalty.","Wyatt Geist named Chief Innovation Officer, Nate Grawey named Chief Commercial Officer; each gets $290K base salary and 138,114 restricted shares.","Portfolio now includes SImmetry, SImmetry+, and SIMPL products, making Tenon a multi-approach sacro-pelvic fusion company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174302,"accession_number":"0001013762-25-004228","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical raises $2.5M in registered direct offering and private placement at $2.00/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Registered direct offering of 1,271,500 shares (or equivalents) at $2.00/share raising ~$2.5M.","Concurrent private placement of warrants to purchase up to 1,271,500 shares at $2.00, exercisable for 5 years.","Sold to a single healthcare institutional investor; priced at-the-market under Nasdaq rules.","Net proceeds for working capital and general corporate purposes; closing expected March 27, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174301,"accession_number":"0001013762-25-003341","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical raises ~$1.46M in registered direct offering and private placement at $2.00/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$1.46M from 733,500 shares (or equivalents) at $2.00/share in registered direct offering.","Concurrent private placement of warrants for 733,500 shares at $2.00, exercisable immediately, 5-year term.","A.G.P./Alliance Global Partners is sole placement agent; receives 7% cash fee plus expenses.","Net proceeds to be used for working capital and general corporate purposes; closing March 26, 2025.","Offering priced at-the-market under Nasdaq rules; filed under effective Form S-3 (May 17, 2023)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174300,"accession_number":"0001213900-25-023304","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Tenon Medical enters warrant inducement; existing warrants exercised at $1.25, ~$3M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Existing warrants for 2,445,700 shares exercised at reduced exercise price of $1.25 per share, down from $4.28.","New Series C-1 (5-year) and C-2 (3-year) warrants issued to purchase 2,445,700 and 1,222,850 shares respectively, both at $1.25.","Aggregate gross proceeds of approximately $3 million, to be used for working capital and general corporate purposes.","A.G.P./Alliance Global Partners earned a cash fee of 7% of gross proceeds as financial advisor.","Company to file resale registration statement within 30 days, target effectiveness in 60 days (90 if full review)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191250,"accession_number":"0001213900-24-085131","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-10-04T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical regains Nasdaq minimum equity compliance after raising ~$9.6M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Aug 23, 2024 for non-compliance with $2.5M minimum stockholders' equity (reported $832K as of June 30).","Raised ~$9.6M net via Series B preferred ($550K), public offering (~$3.95M), warrant inducement (~$4.32M), and warrant exercise ($812K).","As of Oct 3, 2024, company believes it meets the $2.5M minimum equity requirement.","Nasdaq will continue to monitor compliance at the next periodic report; potential delisting if not maintained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207727,"accession_number":"0001213900-24-079515","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Tenon Medical closes $4.5M public offering of shares and warrants at $3.68/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1,222,850 shares (or pre-funded warrants) plus warrants for 1,222,850 shares at $3.68 per unit.","Gross proceeds of approximately $4.5M before fees; warrants exercisable at $3.55, 5-year term.","Net proceeds to fund commercial launch of Catamaran SI Joint System, clinical studies, and working capital.","Offering closed Sep 16, 2024; A.G.P./Alliance Global Partners acted as sole placement agent.","Company agreed to 60-day lock-up on equity issuance and 6-month ban on variable-rate transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207726,"accession_number":"0001213900-24-078903","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Tenon Medical raises ~$4.6M via warrant exercise inducement; issues new warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holder exercises Existing Warrants for 1,222,850 shares at $3.55 each, gross proceeds ~$4.6M.","Company issues new Series A and B warrants each for up to 1,222,850 shares at $4.28, exercisable for 5 and 3 years.","Holder pays $0.125 per new warrant; AGP receives 7% cash fee on gross proceeds as financial advisor.","Net proceeds used for working capital and general corporate purposes.","Company restricted from additional equity issuance for 60 days after resale registration effectiveness and 6 months for variable rate transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207725,"accession_number":"0001213900-24-077584","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical receives Nasdaq delisting notice for insufficient publicly held shares after reverse split","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Tenon on Sept 9, 2024, that publicly held shares of 490,364 are below the 500,000 minimum required by Listing Rule 5550(a)(4).","The shortfall resulted from a 1-for-8 reverse stock split on Sept 6, 2024, reducing outstanding shares from 4,081,767 to 510,221.","Company has until Oct 24, 2024 to submit a plan to regain compliance and expects to do so via a public offering under its Form S-1 filed Aug 14, 2024.","The notification does not immediately affect trading of TNON common stock on The Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207720,"accession_number":"0001213900-24-077047","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K/A","filed_at":"2024-09-10T23:59:59+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"Tenon Medical raises $550K via Series B preferred and warrant private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 86,454 Series B Preferred shares and warrants for 16,214 common shares at $4.2756, raising $550K.","Series B Preferred convertible at holder's option at $5.09 per share, with weighted-average anti-dilution.","Company must file resale registration statement for underlying common shares within 120 days of closing.","Amendment to Series A Preferred Certificate makes Series B pari passu and aligns conversion price with Series B.","Preferred stock votes with common but capped at 9.99% per holder; no dividends payable."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207724,"accession_number":"0001213900-24-076559","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["1.01","1.02","3.02","9.01"],"status":"ready","headline":"Tenon Medical raises $550K via Series B Preferred Stock and warrant private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate offering price of $550,000 for 86,454 Series B Preferred shares and warrants to buy 16,214 common shares at $4.2756.","Series B Preferred convertible into common at $5.09 per share, subject to weighted-average anti-dilution after stockholder approval.","Company may force 50% conversion if VWAP exceeds 250% of conversion price for 10 of 15 days or upon reaching $2.25M quarterly revenue.","Warrants have a five-year term, exercise price $4.2756, and include cashless exercise and anti-dilution rights.","Sale is exempt from registration under Section 4(a)(2) and Regulation D of the Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207723,"accession_number":"0001213900-24-072982","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Tenon Medical appoints Kevin Williamson as CFO effective Sept 3, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Kevin Williamson as CFO, effective Sept 3, 2024, succeeding retiring CFO Steve Van Dick.","Compensation: $315,000 base salary, bonus up to 30% of base, RSU of 50,000 shares with 3-year vesting.","Williamson most recently CFO at Accelus Inc., prior roles at NuVasive; holds B.S. and MBA.","Company cites upcoming catalysts: full enrollment of post-market clinical trial for Catamaran SI Joint Fusion System.","Severance: 100% of base salary for 12 months if terminated without cause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207722,"accession_number":"0001213900-24-072610","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical receives Nasdaq delisting notice for failing minimum equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of $832k as of June 30, 2024, below Nasdaq's $2.5M minimum requirement.","Company has until October 7, 2024 to submit a compliance plan; extension up to 180 days possible.","If plan rejected or compliance not regained, securities subject to delisting; appeal to Hearings Panel available.","Current listing and trading of common stock and warrants on Nasdaq not immediately affected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207721,"accession_number":"0001013762-24-001130","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tenon Medical shareholders approve director elections, equity plan amendment, and Series B terms at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with majority support; broker non-votes ~1.2M shares.","Shareholders approved Series B Preferred Stock terms and warrant issuance; vote 2,391,579 for, 45,130 against.","2022 Equity Incentive Plan amended to add 1,100,000 shares; approved 2,318,386 for, 117,137 against.","Haskell & White LLP ratified as independent auditor for FY2024; 3,609,093 for, 11,604 against.","Adjournment proposal approved to solicit additional proxies if needed; 2,720,153 for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225195,"accession_number":"0001213900-24-045900","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-05-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tenon Medical CFO Steven Van Dick to retire effective July 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Steven Van Dick to resign effective July 31, 2024; will consult post-resignation.","Company actively searching for a qualified CFO candidate.","Van Dick will provide transition assistance and strategic advice after leaving."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225194,"accession_number":"0001213900-24-040903","cik":1560293,"company_name":"Tenon Medical, Inc.","ticker":"TNON","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tenon Medical receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq letter dated May 7, 2024, citing 30 consecutive business days below $1.00 minimum bid price from Mar 25 to May 6.","Initial 180-day compliance period runs until November 4, 2024, to regain compliance with Bid Price Rule.","If not cured, company may qualify for a second 180-day period if it meets other listing standards and notifies intent to cure.","Company is evaluating options; no immediate impact on listing, but no assurance of regaining compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8050475.9953763895,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}